Asaf Zviran, PhD, CEO & CSO, presented his company C2i Genomics on January 25, 2023 at the Precision Medicine World Conference (PMWC 2023). Dr. Zviran is a veteran of the Israeli military where his specialty was radar. But when he developed thymus cancer, and then saw cancer also afflict different family members, he decided to focus on cancer to try to use his sophisticated engineering knowledge in combination with newly learned biotechnology to fight this often-fatal scourge. As a co-inventor of the technology used at C2i Genomics, Dr. Asaf led the company development from academy research concept to VC-backed growth-stage company. Dr. Zviran brings over 15 years of R&D management in life science and defense, including numerous high-impact scientific publications and patents. As a cancer survivor, Asaf is committed to improving cancer patients’ quality of life and outcomes.